SREBF2 and fatty liver disease: The markedly reduced expression of lipogenic genes in hepatocyte-Srebf-2-/- livers and the blunted response of these genes to refeeding a high carbohydrate diet suggest that blocking SREBP-2 action would also be effective in preventing the development of hepatic steatosis induced by hyperinsulinemia, similar to the results obtained in Scap deficient mice that also lack leptin (Moon et al., 2012).